Modified FOLFIRINOX for unresectable locally advanced/metastatic pancreatic cancer. A real-world comparison of an attenuated with a full dose in a single center experience

Purpose: Metastatic pancreatic adenocarcinoma has a very poor prognosis. Although irinotecan, oxaliplatin and leucovorin-modulated fluorouracil (FOLFIRINOX) significantly increases survival in advanced pancreatic cancer, compared to employing only gemcitabine (GEM), toxicities have tempered enthusia...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:Onco Targets Ther
Main Authors: Cavanna, Luigi, Stroppa, Elisa Maria, Citterio, Chiara, Mordenti, Patrizia, Di Nunzio, Camilla, Peveri, Silvia, Orlandi, Elena, Vecchia, Stefano
Format: Artigo
Sprog:Inglês
Udgivet: Dove 2019
Fag:
Original Research
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC6498392/
https://ncbi.nlm.nih.gov/pubmed/31118666
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/OTT.S200754
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker